Open AccessGCN2 kinase activation by ATP-competitive kinase inhibitors
Author(s) -
Colin P. Tang,
Owen Clark,
John R. Ferrarone,
Carl Campos,
Alshad S. Lalani,
John D. Chodera,
Andrew M. Intlekofer,
Olivier Elemento,
Ingo K. Mellinghoff
Publication year - 2021
Publication title -
nature chemical biology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.412
H-Index - 216
eISSN - 1552-4469
pISSN - 1552-4450
DOI - 10.1038/s41589-021-00947-8
Subject(s) - neratinib , kinase , erbb , cancer research , microbiology and biotechnology , mtorc1 , biology , chemistry , signal transduction , cancer , genetics , pi3k/akt/mtor pathway , trastuzumab , breast cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom